Impact of Genomic Alterations on Efficacy of Trastuzumab Deruxtecan Against Human Epidermal Growth Factor Receptor-2-Positive Advanced Gastric Cancer.
Yamaguchi K, Ito M, Isobe T, Koreishi S, Taguchi R, Uehara K, Ueno S, Imajima T, Kitazono T, Tsuchihashi K, Ohmura H, Yoshihiro T, Tanoue K, Nishiyori S, Iwama E, Maeda T, Akashi K, Baba E.
Yamaguchi K, et al. Among authors: uehara k.
JCO Precis Oncol. 2024 May;8:e2300681. doi: 10.1200/PO.23.00681.
JCO Precis Oncol. 2024.
PMID: 38748981